Table 1.
Baseline Characteristics of COVID-19 Patients vs. Healthy Volunteers.
| COVID-19 (n = 67) | Healthy Volunteers (n = 38) | p-valuea | |
|---|---|---|---|
| Age (years) | 58 [33, 71] | 41 [30, 51] | 0.002 |
| Sex (% male) | 30 (44.8%) | 19 (50.0%) | 0.686 |
| Taking anti-platelets at the time of sample collection (%) | 11 (16.4%) | 0 (0%) | 0.007 |
| Days since COVID-19 PCR test | 5 [1,9] | – | – |
| Symptomatic (%) | 66 (98.5%) | – | – |
| Days of symptoms prior to sample collection | 8 [4,10] | – | – |
| Hypertension (%) | 23 (34.3%) | 4 (10.5%) | 0.010 |
| Hyperlipidemia (%) | 15 (22.4%) | 9 (23.7%) | >0.999 |
| Diabetes Mellitus (%) | 11 (16.4%) | 3 (7.9%) | 0.251 |
| Chronic Kidney Disease (%) | 8 (11.9%) | 0 (0.0%) | 0.049 |
| COPD/Asthma (%) | 17 (25.4%) | 5 (13.2%) | 0.212 |
a
p-value < 0.05 is considered statistically significant, and noted in bold text.